E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/9/2022 in the Prospect News Structured Products Daily.

New Issue: JPMorgan sells $1.73 million capped buffered enhanced participation equity notes on ETF

By William Gullotti

Buffalo, N.Y., Nov. 9 – JPMorgan Chase Financial Co. LLC priced $1.73 million of 0% capped buffered enhanced participation equity notes due May 8, 2024 linked to the Health Care Select Sector SPDR Fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by JPMorgan Chase & Co.

If the ETF return greater than the initial level, the payout at maturity will be par plus 1.5 times the ETF return, subject to a maximum settlement amount of par plus 25.575%.

If the ETF return is flat, or greater than or equal to the 90% buffer level, investors will receive par.

If the ETF falls by more than 10%, investors will lose 1.1111% for each 1% decline beyond the buffer.

J.P. Morgan Securities LLC is the agent.

Issuer:JPMorgan Chase Financial Co. LLC
Guarantor:JPMorgan Chase & Co.
Issue:Capped buffered enhanced participation equity notes
Underlying fund:Health Care Select Sector SPDR Fund
Amount:$1,725,000
Maturity:May 8, 2024
Coupon:0%
Price:Par
Payout at maturity:If ETF gains, par plus 1.5 times the gain, capped at par plus 25.575%; if the ETF is flat, or greater than or equal to the 90% buffer level, par; if the ETF falls below the 10% buffer, investors will lose 1.1111% for each 1% decline beyond 10%
Initial level:$130.81
Buffer level:90% of initial ETF level
Pricing date:Nov. 4
Settlement date:Nov. 14
Agent:J.P. Morgan Securities LLC
Fees:1.51%
Cusip:48133PLQ4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.